Synthesis, Biological Activities, and X-ray Crystal Structural Analysis of

Nov 27, 2015 - In our previous design of vitamin D analogues (2–4), we introduced the terminal adamantane ring to change the H12 conformation by ste...
0 downloads 11 Views 4MB Size
Subscriber access provided by University of Sussex Library

Article

Synthesis, Biological Activities and X-ray Crystal Structural Analysis of 25-Hydroxy-25(or 26)-adamantyl-17[20(22),23-diynyl]-21-norvitamin D Compounds Yusuke Watarai, Michiyasu Ishizawa, Teikichi Ikura, Flavia C.M. Zacconi, Shigeru Uno, Nobutoshi Ito, Antonio Mouriño, Hiroaki Tokiwa, Makoto Makishima, and Sachiko Yamada J. Med. Chem., Just Accepted Manuscript • DOI: 10.1021/acs.jmedchem.5b00792 • Publication Date (Web): 27 Nov 2015 Downloaded from http://pubs.acs.org on November 29, 2015

Just Accepted “Just Accepted” manuscripts have been peer-reviewed and accepted for publication. They are posted online prior to technical editing, formatting for publication and author proofing. The American Chemical Society provides “Just Accepted” as a free service to the research community to expedite the dissemination of scientific material as soon as possible after acceptance. “Just Accepted” manuscripts appear in full in PDF format accompanied by an HTML abstract. “Just Accepted” manuscripts have been fully peer reviewed, but should not be considered the official version of record. They are accessible to all readers and citable by the Digital Object Identifier (DOI®). “Just Accepted” is an optional service offered to authors. Therefore, the “Just Accepted” Web site may not include all articles that will be published in the journal. After a manuscript is technically edited and formatted, it will be removed from the “Just Accepted” Web site and published as an ASAP article. Note that technical editing may introduce minor changes to the manuscript text and/or graphics which could affect content, and all legal disclaimers and ethical guidelines that apply to the journal pertain. ACS cannot be held responsible for errors or consequences arising from the use of information contained in these “Just Accepted” manuscripts.

Journal of Medicinal Chemistry is published by the American Chemical Society. 1155 Sixteenth Street N.W., Washington, DC 20036 Published by American Chemical Society. Copyright © American Chemical Society. However, no copyright claim is made to original U.S. Government works, or works produced by employees of any Commonwealth realm Crown government in the course of their duties.

Page 1 of 63

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Journal of Medicinal Chemistry

Synthesis, Biological Activities and X-ray Crystal Structural Analysis of 25-Hydroxy-25(or 26)-adamantyl-17-[20(22),23diynyl]-21-norvitamin D Compounds Yusuke Watarai,§ Michiyasu Ishizawa,‡ Teikichi Ikura,¶ Flavia C.M. Zacconi,† Shigeyuki Uno,‡ Nobutoshi Ito,¶ Antonio Mouriño,† Hiroaki Tokiwa,§ Makoto Makishima,‡* and Sachiko Yamada‡* §

Department of Chemistry, Faculty of Science, Rikkyo University, Toshima-ku, Tokyo 1718501, Japan



Department of Biomedical Sciences, Nihon University School of Medicine, Itabashi-ku, Tokyo 173-8610, Japan ¶

Medical Research Institute, Tokyo Medical and Dental University, Bunkyo-ku, Tokyo1138510, Japan



Departamento de Química Orgánica, Laboratorio de Investigación Ignacio Ribas, Universidad de Santiago de Compostela, 15782 Santiago de Compostela, Spain

ABSTRACT: Novel 19-norvitamin D analogs (ADYW1-4, 5a-d) in which an adamantyl diyne side chain is attached directly to the 17-position of the D ring are designed and stereoselectively synthesized. The adamantane ring of these analogs was expected to interfere with helix 12 (H12, activation function 2) of the vitamin D receptor (VDR) to modulate its activities. The analog 5b

ACS Paragon Plus Environment

1

Journal of Medicinal Chemistry

1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60

Page 2 of 63

binds to the VDR (7% of the natural hormone) and shows significant partial agonistic activity in transactivation assay. Compound 5b showed considerable selectivity in VDR target genes expressions in vitro, it was taken up by target cells 2-3 times more readily, and its life time was three times longer than the natural hormone. The X-ray crystal structure of 5b in complex with VDR reveals that the ligand binds similarly to the natural hormone, but the diyne moiety is slightly bent (angles around the diyne 5 to 8 º) with respect to the original diyne vitamin D compound 6 in VDR (